OraLiva Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2M
- Investors
-
15
OraLiva General Information
Description
Developer of an AI-powered cytology diagnostic platform designed to help early cancer detection and precision oncology care at the point-of-care. The company's platform offers scalable, non-invasive diagnostic tests using advanced AI algorithms, enabling healthcare providers to make faster, more accurate diagnostic decisions, improving patient outcomes, and facilitating early disease intervention.
Contact Information
Website
www.oraliva.comCorporate Office
- New York, NY
- United States
Corporate Office
- New York, NY
- United States
OraLiva Timeline
OraLiva Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | 06-Oct-2025 | $2M | Completed | Generating Revenue | ||
| 6. Grant | 01-Jan-2025 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Accelerator/Incubator | 21-Jun-2024 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 13-Oct-2023 | Completed | Generating Revenue | |||
| 1. Grant | 15-Feb-2023 | $275K | Completed | Generating Revenue |
OraLiva Comparisons
Industry
Financing
Details
OraLiva Competitors (4)
One of OraLiva’s 4 competitors is Vigilant Biosciences, a Venture Capital-Backed company based in Lakeway, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vigilant Biosciences | Venture Capital-Backed | Lakeway, TX | ||||
| OrisDX | Venture Capital-Backed | Chicago, IL | ||||
| Viome Life Sciences | Venture Capital-Backed | Bellevue, WA | ||||
| CDx Diagnostics | Private Equity-Backed | Suffern, NY |
OraLiva Signals
OraLiva Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| American Heart Association Ventures | Corporate Venture Capital | Minority | ||
| DCVC | Venture Capital | Minority | ||
| New York University | University | Minority | ||
| NYU Entrepreneurial Institute | Accelerator/Incubator | Minority | ||
| Angel (individual) | Minority |
OraLiva FAQs
-
When was OraLiva founded?
OraLiva was founded in 2019.
-
Where is OraLiva headquartered?
OraLiva is headquartered in New York, NY.
-
What is the size of OraLiva?
OraLiva has 3 total employees.
-
What industry is OraLiva in?
OraLiva’s primary industry is Diagnostic Equipment.
-
Is OraLiva a private or public company?
OraLiva is a Private company.
-
What is OraLiva’s current revenue?
The current revenue for OraLiva is .
-
How much funding has OraLiva raised over time?
OraLiva has raised $2M.
-
Who are OraLiva’s investors?
American Heart Association Ventures, DCVC, New York University, NYU Entrepreneurial Institute, and are 5 of 15 investors who have invested in OraLiva.
-
Who are OraLiva’s competitors?
Vigilant Biosciences, OrisDX, Viome Life Sciences, and CDx Diagnostics are competitors of OraLiva.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process